2
ORAL PRESENTATION Open Access Pathological CMR findings and their clinical value in patients with high grade ventricular arrythmias without previously known cardiac conditions Daniel Thomas 1* , Claas P Naehle 1 , Darius Dabir 1 , Hans Schild 1 , Georg Nickenig 1 , Victor A Ferrari 2 , Jutta Weisser-Thomas 1 From 2011 SCMR/Euro CMR Joint Scientific Sessions Nice, France. 3-6 February 2011 Introduction Recent studies have demonstrated the ability of CMR to identify the anatomic correlate of high grade ventri- cular arrhythmia (VA) in HCM and CHD patients. However, little is known about the value of CMR in patients with VAs, without previously known cardiac conditions. Purpose To investigate the value of CMR for detection of under- lying heart disease and arrhythmogenic substrate in patients with VAs. Methods Patients with VAs, without known cardiac condition were included (n=71). CMR, echocardiography and 12-lead ECGs were performed in all patients. Most patients underwent electrophysiologic testing (EPS). CMR findings were correlated with ECG and/or EPS findings. A morphological substrate was defined as 1) underlying cardiac condition detected by CMR, known to cause associated arrhythmia, or 2) presence of an electro-anatomic correlate, if the location of a structural abnormality/scar tissue, matched the origin of the VA as defined by ECG and/or EPS. A positive CMR finding was defined as clinically relevant if 1) it resulted in a new diagnosis, or 2) a change of treatment, or 3) addi- tional diagnostic procedures. Results Pathological CMR findings were found in 42 patients. The main findings were wall motion abnormalities (n=22), ventricular hypertrophy (n=10), dilatation (LV or RV or atrium, total=28), wall thinning (n=3), pericar- dial and/or pleural effusion (n=6), myocardial scar/struc- tural abnormalies (n=14). Based on CMR a diagnosis of heart disease was estab- lished in 19 patients (27%; DCM n = 3, HCM n = 1, cri- teria for ARCM n = 2, post-myocarditis scar n = 7, post-myocardial infarction scar n = 2, myocarditis n = 4). In 15/71 patients (21%) the definite diagnosis was obtained by CMR exclusively. All CMR based diagnoses were classified as morphological substrates. In 8 patients the location of the relevant CMR finding (myocardial scar) directly matched the origin of the VA as defined by ECG or EPS. In none of these patients the relevant finding was detected by echocardiography. The diag- noses resulted in a change of treatment in 11 patients (15%) and a change of treatment plus additional diag- nostic procedures in 8 patients (11%). Conclusions This is the first study revealing the value of CMR for detec- tion of the morphological substrate and/or underlying car- diac condition in patients with VAs, without any previously known cardiac disease. The high incidence of clinically relevant CMR findings raises the question, whether CMR should routinely be performed in those patients. Author details 1 University of Bonn, Bonn, Germany. 2 University of Pennsylvania, Philadelphia, PA, USA. 1 University of Bonn, Bonn, Germany Full list of author information is available at the end of the article Thomas et al. Journal of Cardiovascular Magnetic Resonance 2011, 13(Suppl 1):O42 http://jcmr-online.com/content/13/S1/O42 © 2011 Thomas et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Pathological CMR findings and their clinical value in patients with high grade ventricular arrythmias without previously known cardiac conditions

Embed Size (px)

Citation preview

ORAL PRESENTATION Open Access

Pathological CMR findings and their clinical valuein patients with high grade ventricular arrythmiaswithout previously known cardiac conditionsDaniel Thomas1*, Claas P Naehle1, Darius Dabir1, Hans Schild1, Georg Nickenig1, Victor A Ferrari2,Jutta Weisser-Thomas1

From 2011 SCMR/Euro CMR Joint Scientific SessionsNice, France. 3-6 February 2011

IntroductionRecent studies have demonstrated the ability of CMRto identify the anatomic correlate of high grade ventri-cular arrhythmia (VA) in HCM and CHD patients.However, little is known about the value of CMR inpatients with VAs, without previously known cardiacconditions.

PurposeTo investigate the value of CMR for detection of under-lying heart disease and arrhythmogenic substrate inpatients with VAs.

MethodsPatients with VAs, without known cardiac conditionwere included (n=71). CMR, echocardiography and12-lead ECGs were performed in all patients. Mostpatients underwent electrophysiologic testing (EPS).CMR findings were correlated with ECG and/or EPSfindings. A morphological substrate was defined as 1)underlying cardiac condition detected by CMR, knownto cause associated arrhythmia, or 2) presence of anelectro-anatomic correlate, if the location of a structuralabnormality/scar tissue, matched the origin of the VA asdefined by ECG and/or EPS. A positive CMR findingwas defined as clinically relevant if 1) it resulted in anew diagnosis, or 2) a change of treatment, or 3) addi-tional diagnostic procedures.

ResultsPathological CMR findings were found in 42 patients.The main findings were wall motion abnormalities(n=22), ventricular hypertrophy (n=10), dilatation (LVor RV or atrium, total=28), wall thinning (n=3), pericar-dial and/or pleural effusion (n=6), myocardial scar/struc-tural abnormalies (n=14).Based on CMR a diagnosis of heart disease was estab-

lished in 19 patients (27%; DCM n = 3, HCM n = 1, cri-teria for ARCM n = 2, post-myocarditis scar n = 7,post-myocardial infarction scar n = 2, myocarditis n =4). In 15/71 patients (21%) the definite diagnosis wasobtained by CMR exclusively. All CMR based diagnoseswere classified as morphological substrates. In 8 patientsthe location of the relevant CMR finding (myocardialscar) directly matched the origin of the VA as definedby ECG or EPS. In none of these patients the relevantfinding was detected by echocardiography. The diag-noses resulted in a change of treatment in 11 patients(15%) and a change of treatment plus additional diag-nostic procedures in 8 patients (11%).

ConclusionsThis is the first study revealing the value of CMR for detec-tion of the morphological substrate and/or underlying car-diac condition in patients with VAs, without any previouslyknown cardiac disease. The high incidence of clinicallyrelevant CMR findings raises the question, whether CMRshould routinely be performed in those patients.

Author details1University of Bonn, Bonn, Germany. 2University of Pennsylvania,Philadelphia, PA, USA.

1University of Bonn, Bonn, GermanyFull list of author information is available at the end of the article

Thomas et al. Journal of Cardiovascular Magnetic Resonance 2011, 13(Suppl 1):O42http://jcmr-online.com/content/13/S1/O42

© 2011 Thomas et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative CommonsAttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction inany medium, provided the original work is properly cited.

Published: 2 February 2011

doi:10.1186/1532-429X-13-S1-O42Cite this article as: Thomas et al.: Pathological CMR findings and theirclinical value in patients with high grade ventricular arrythmias withoutpreviously known cardiac conditions. Journal of Cardiovascular MagneticResonance 2011 13(Suppl 1):O42.

Submit your next manuscript to BioMed Centraland take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit

Thomas et al. Journal of Cardiovascular Magnetic Resonance 2011, 13(Suppl 1):O42http://jcmr-online.com/content/13/S1/O42

Page 2 of 2